Sie sind hier: Programm > Friday, Dec. 2nd, 2016

PROGRAMME FRIDAY

► Carotid    ► Aortic    ► Peripheral artery disease    ► Poster Session    ► Workshop/Seminar    ► Venous
 
Lecture Hall B
 

08.30-10.00

MAC 2
Molecular, genetic and mechanistic factors in aortic diseases

 

Chairs:
G. Holzapfel, Austria
L. Maegdefessel, Germany

Keynote lecture: Molecular, genetic and mechanistic factors involved in AAA development

 

P. Tsao, USA

Experimental models of aneurysm development and expansion

 

A. Busch, Sweden

Pathological vascular remodelling in abdominal aortic aneurysm

 

M. Bailey, UK

Segmental aortic stiffness is a mechanical driver of AAA development

 

U. Raaz*, Germany

Neutrophil extracellular traps in abdominal aortic aneurysm

 

W. Eilenberg*, Austria

18FDG-PET imaging of unstable AAAs using microRNA signatures

 

N. Sakalihasan, Belgium

Physical activity and the risk to develop AAA

 

M. Björck, Sweden

 
10.00-10.25
COFFEE BREAK
 

10.25-11.25

MAC 3
Repair of the ascending aorta and the aortic arch

 

Chairs:
C. Dzsinich, Hungary
J. Schmidli, Switzerland

Frozen elephant trunk technique for aortic arch replacement

 

F. Beyersdorf, Germany

Advances in endografting of the aortic arch and its branches

 

S. Haulon, France

Ascending and arch branch endografts including carbon dioxide flushing to prevent air embolism

 

T. Kölbel, Germany

Early experience with a single branch device for the arch

 

M. Makaroun, USA

Initial clinical experience with an orthotopic endovascular solution for aortic arch pathology

 

M. Czerny, Germany

Hybrid treatment of the ascending aorta and arch in acute Type I dissection

 

H. G. Jakob, Germany

11.25-12.25

MAC 4
Advances in EVAR and open repair for complex aneurysms and dissections

 

Chairs:
H. G. Jakob, Germany
M. Makaroun, USA

Results from a nationwide registry on scalloped thoracic stent grafts for short landing zones

 

C. Zeebregts, The Netherlands

Update on false lumen embolisation strategies in aortic dissections

 

T. Kölbel, Germany

5-years results of fenestrated (FEVAR) and branched (BEVAR) endografting for post-dissection aneurysms

 

E. Verhoeven, Germany

Acute non-A non-B aortic dissection: definition, treatment and outcome

 

B. Rylski*, Germany

Repair of emergent thoracoabdominal aneurysms using off-the-shelf devices

 

B. Modarai, UK

The role of endostapling in TEVAR and fenestrated grafts (supported by an educational grant of Medtronic)

 

P. Kasprzak, Germany

The role of in situ fenestration in complex aortic repair

 

R. Kolvenbach, Germany

 
12.25-13.25
LUNCH BREAK
 

13.25-13.40

Special lecture: Why the European qualification in vascular surgery (FEBVS) will be even more important in the future!

 

A. Mansilha, Portugal

13.40-14.35

MAC 5
Spinal cord protection in aortic surgery – evolving concepts to minimize the risk of paraplegia

 

Chairs:
N. Sakalihasan, Belgium
F. Beyersdorf, Germany

Current strategies to prevent spinal cord ischemia in thoracoabdominal aortic aneurysm repair

 

G. W. Schurink, The Netherlands

The value of temporary aneurysm sac perfusion, MEP and spinal drainage in complex endovascular aortic repair

 

P. Kasprzak, Germany

Is CSF drainage really mandatory in branched endografting for TAAA?

 

E. Verhoeven, Germany

Minimally invasive selective segmental artery coil-embolization (MISACE): The papaARTIS trial

 

C. Etz, Germany

Imaging of spinal cord perfusion – first results of a new technique

 

A. Huber, Germany
S. Geisbüsch, Germany

14.35-15.45

MAC 6
Advances in (P)EVAR for elective and ruptured AAA and the management of type I endoleaks

 

Chairs:
T. Cohnert, Austria
L. Lönn, Denmark
F. Veith, USA

A comparison of percutaneous femoral access in EVAR versus open femoral access (PiERO): randomized controlled trial

 

C. Zeebregts, The Netherlands

The fascial suture technique as closure procedure of the femoral arteries after EVAR – not only a bail technique!

 

M. Malina, Sweden

AAAs >55mm are more likely associated with hostile proximal neck: A potential need for reappraisal of diametre threshold to intervene in the EVAR era

 

A. Giannoukas, Greece

Endostapling in the prevention and treatment of type Ia endoleaks in the abdominal aorta (supported by an educational grant of Medtronic)

 

R. Kolvenbach, Germany

FEVAR for failed endovascular aortic repair

 

A. Assadian, Austria

Late rupture after EVAR is still an unsolved problem: analysis of causes, treatments and outcomes

 

V. Makaloski*, Switzerland

Tipps and tricks to successfully treat juxtarenal ruptured AAA by EVAR

 

M. Malina, Sweden

Ruptured juxtarenal AAA are better treated by open surgery

 

J. Schmidli, Switzerland

 
15.45-16.10
COFFEE BREAK
 

16.10-17.05

MAC 7
How to prevent and to treat type II endoleaks – a never ending story

 

Chairs:
S. Haulon, France
M. Malina, Sweden

How and when to do sac embolization during EVAR

 

A. Stella, Italy

Keynote lecture: Prevalence and natural history of type II endoleaks – or: do we still midjudge a potentially dangerous condition?

 

M. Makaroun, USA

Predictors of endoleak type II risk, in the era of prevention with aneurysm sac filling during EVAR

 

F. Grego, Italy

Are there any indications for preoperative embolisation of lumbar arteries and/or the IMA

 

L. Lönn, Denmark

Embolisation techniques of type II endoleaks (supported by an educational grant of Medtronic)

 

A. Zimmermann, Germany

17.05-18.15

MAC 8
Special session on radiation safety and team training

 

Chairs:
C. Liapis, Greece
S. MacDonald, USA
E. Verhoeven, Germany

Biodosimetric assessment of the effects of radiation exposure after endovascular intervention

 

B. Modarai, UK

Ongoing radiation safety simulation training project: Update from Copenhagen, Denmark

 

L. Lönn, Denmark

Improving safety and work flow in the Hybrid OR: the HOT (Hybrid Operation Technician) concept

 

J. Gahlen, Germany

Impact of the use of intraoperative extra low dose imaging protocols

 

N. Dias, Sweden

How to achieve optimal imaging in the Hybrid OR and to reduce radiation (according to the ALARA criteria) at the same time

 

S. Haulon, France

Optimal use of the Clarity system to reduce radiation for patients and staff

 

J. Tessarek, Germany

How do we increase risk of TEVAR/EVAR by the use of Vessel Navigator

 

J. Brunkwall, Germany

Development of an assessment instrument for advanced simulations training of EndoVascular on Aortic Repair

 

L. Lönn, Denmark

 
Conference Room 1 (Workshops / Seminars)
 

09.00-10.00

MENTICE AB
Hands-on simulator training II

 

L. Lönn, Denmark

 
10.00-10.25
COFFEE BREAK
 

10.25-11.25


 

OPTIMED GMBH
Venous stents – a challenge for men and material

 

K. Kipp, Germany

11.25-12.25

Experimental vascular models and vascular biobanking

 

L. Maegdefessel, Germany

 
12.25-13.25
LUNCH BREAK
 

13.25-13.40
Lecture Hall B

Special lecture: Why the European qualification in vascular surgery (FEBVS) will be even more important in the future!

 

A. Mansilha, Portugal

13.40-14.35

Cruro-pedal bypass surgery - indications and techniques

 

A. Neufang, Germany

14.35-15.45

 

 

Cardiovascular risk assessment in major (endo)vascular surgery

 

J. Scott, UK
T. Stadlbauer, Germany

 
15.45-16.10
COFFEE BREAK
 

16.10-17.05

Carotid-artery stenting (CAS) step-by-step – how to implement a CAS programme – experiences of a pioneer

 

K. Mathias, Germany

17.05-18.15

C.R. BARD GmbH
Endovascular techniques for chronic lesions of the iliac veins

 

H. Jalaie, Germany

 
Lecture Hall Pavillon
 

08.30-09.10

PAD 1
Popliteal diseases

 

Chairs:
J. Gahlen, Germany
A. Giannoukas, Greece

Keynote lecture: The natural history of popliteal artery aneurysms (PAA). When should it be excluded and does anticoagulation play a role before or after surgery?

 

M. Björck, Sweden

Current use of endorepair for popliteal aneurysms (PAA)

 

M. Makaroun, USA

Five year outcomes of surgical treatment for popliteal artery entrapment syndrome

 

N. Chakfe, France

09.10-10.00

PAD 2
Hot topics on popliteal diseases, acute ischaemia and chronic limb ischaemia

 

Chairs:
F. Grego, Italy
M. Steinbauer, Germany

Current status of controlled limb reperfusion

 

F. Beyersdorf, Germany

Acute lower limb ischaemia in patients with cancer

 

J. Scott, UK

Bioresorbable everolimus-eluting vascular scaffold for patients with peripheral artery disease (ESPRIT I): 2-Year clinical and imaging results

 

F. Wolf, Austria

Negative pressure wound therapy versus standard wound care in chronic diabetic foot wounds: a randomized controlled trial

 

M. Storck, Germany

Quality of time spent without symptoms of disease or toxicity of treatment (Q-TWiST) in diabetic patients with CLI and digital gangrene. Does primary TMA after revascularization offer superior outcome? A 12-year Experience

 

M. Elsherif*, Ireland

 
10.00-10.25
COFFEE BREAK
 

10.25-11.25

PAD 3
Vascular calcifications – impact on treatment and outcomes

 

Chairs:
N. Chakfe, France
C. Espinola-Klein, Germany
K.-L. Laugwitz, Germany

Biological mechanisms of severe vascular calcifications – do those patients need a more aggressive primary or secondary medical prevention strategy?

 

C. Liapis, Greece

The amount of aortic calcification is predictive for the rupture risk in AAA – is aortic calcification also predictive for other cardiovascular complications?

 

C. Zeebregts, The Netherlands

Calcium score as a predictor of survival after EVAR

 

N. Dias, Sweden

Calcification at the carotid bifurcation – an indicator for stability or instability?

 

P. Ringleb, Germany

Techniques and results of infrainguinal endovascular recanalizations in heavily calcified peripheral arteries

 

M. Fusaro, Germany

11.25-12.25

PAD 4
Restenoses after open or endovascular recanalizations and complex primary peripheral lesions

 

Chairs:
G. de Borst, The Netherlands
J. Scott, UK

Pathobiology of neointimal hyperplasia and restenosis: Lessons from cell biology and animal models

 

M. Wildgruber, Germany

The impact of neoatherosclerosis after drug-eluting
stents/balloons

 

M. Joner, Germany

Restenosis after infrainguinal vein bypasses – plain balloon angioplasty, drug-eluting balloon (DEB), stenting or surgical correction?

 

J. Brunkwall, Germany

In-stent-restenosis – are DEB the best way to go or should we use stentgrafts in this situation?

 

M. Fusaro, Germany

Which peripheral lesions should be treated primarily by DEB rather than plain balloons or stents?

 

I. van Herzeele, Belgium

 
12.25-13.25
LUNCH BREAK
 

13.25-13.40
Lecture Hall B

Special lecture: Why the European qualification in vascular surgery (FEBVS) will be even more important in the future!

 

A. Mansilha, Portugal

13.40-15.10

PAD 5
Translational research of peripheral and carotid atherosclerosis

 

Chairs:
L. Maegdefessel, Germany
M. Wildgruber, Germany

Keynote lecture: Transcriptomic insights into carotid artery plaque vulnerability

 

U. Hedin, Sweden

Neutrophils in atherosclerosis – from initiation to destabilisation

 

O. Söhnlein, Germany

The long non-coding RNA MIAT regulates smooth muscle cell proliferation and macrophage activity in advanced atherosclerotic lesions

 

Y. Li*, Sweden

Transcription factor Runx2 is induced in vascular aging and may promote age-related arterial stiffness

 

I. Schellinger*, Germany

Developing novel therapies for the critically ischemic limb: encapsulated angiogenic cells

 

B. Modarai, UK

 
15.45-16.10
COFFEE BREAK
 

16.10-17.20

Poster Session II
Carotid and peripheral vascular diseases

 

 

17.20-18.15

PAD 6
Periprocedural medication after open and endovascular PAD therapy

 

Chairs:
A. Algra, The Netherland
M. Storck, Germany

Current and novel pharmaceutical treatment opportunities for patients with PAD

 

C. Espinola-Klein, Germany

There is NO evidence for dual antiplatelet therapy in peripheral arterial disease interventions and the sense or nonsense of individual platelet function testing

 

G. de Borst, The Netherlands

Rationale and design of the VOYAGER Trial

 

H. Lawall, Germany

Intermediate dose of Tinzaparin for the treatment of superficial vein thrombosis: Results from a national multicentre study – the SEVEN Study

 

A. Giannoukas, Greece

Optimal medical adjuncts for distal leg bypasses – experiences from a dedicated and very experienced bypass surgeon

 

A. Neufang, Germany

19.30
GET TOGETHER
 

*Abstract, competing for the MAC Award for the best oral presentation